ECOG-ACRIN Network Group Operations Center
Funded at Ecog-Acrin Medical Research Foundation · NIH-11289825 · Data updated 2026-11-12
A national cancer research network coordinates advanced imaging, biology, and clinical trials to study and improve treatments for adults with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ecog-Acrin Medical Research Foundation NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 29, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $9,405,328 |
| NIH project number | 2U10CA180820-12 |
| Project ID | NIH-11289825 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults (21+ years) with cancer who may participate in biomarker-driven clinical trials or contribute samples to translational studies.
✕Less likely to help
Patients with cancers not covered by the center's immediate biomarker-focused trials or those unable to participate in clinical trials may see limited direct benefit.
What this research studies
This grant supports a national center that blends imaging, biology, and clinical trial work to test new cancer therapies in adults. It coordinates data management, biorepositories, and translational science to link laboratory findings with patient outcomes. The goal is to enable precise, biomarker-driven clinical trials that can reach diverse populations across the US. Researchers work with biostatistics and data centers to ensure robust analysis and broad trial access, from large centers to community practices. This center drives science that can translate into better care for adults living with cancer.
Why it matters
Potential benefit: If successful, patients could benefit from faster access to precisely targeted therapies guided by biomarkers.
How similar studies have gone: Previous biomarker-driven cancer trials have shown that integrating biology with imaging can improve trial efficiency and treatment matching.
Where this research is happening
-
Ecog-Acrin Medical Research Foundation
Philadelphia, United States Active
Researchers
- Principal investigator: Odwyer, Peter J — Ecog-Acrin Medical Research Foundation
- Study coordinator: Odwyer, Peter J
Related research
Other NIH-funded projects on the same topics.
-
ECOG-ACRIN NCORP Research Base overview for cancer care and prevention
A national cancer research network is running patient-centered trials and biomarker work through community sites to improve prevention, early detection, treatment, and survivorship.
-
Biorepository for Cancer Biospecimens to Advance Cancer Care
A national cancer biorepository program will securely collect, store, and share labeled tissue, blood, and other biospecimens from cancer patients to help researchers develop better tests and treatments.
-
ECOG-ACRIN cancer clinical trials network
This program runs cancer clinical trials and prevention studies to expand treatment options and improve quality of life for people with cancer and cancer survivors.
-
Support Toolkit to Boost Cancer Clinical Trial Participation
A multi-level program to help more cancer patients join NCI-supported clinical trials using a patient-friendly literacy tool and navigators.
-
ECOG-ACRIN Community Cancer Research Network
This program runs clinical trials and prevention projects to improve cancer care and quality of life for people treated in community clinics.
-
Member Site Core (cancer trials network core for biomarker-driven research)
A nationwide cancer trial network core is advancing biomarker-guided therapies by linking imaging, biology, and clinical trials to improve care for adults with cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.